Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04562844
Other study ID # 2018-A00170-55
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date September 24, 2020
Est. completion date December 31, 2023

Study information

Verified date July 2020
Source Centre d'Investigation Clinique et Technologique 805
Contact Claire Vallat Azouvi, PhD
Phone 01 47 10 76 46
Email claire.vallat-azouvi@univ-paris8.fr
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Patients who have suffered moderate to severe traumatic brain injury (TBI) frequently develop behavioural changes, which can have deleterious consequences on interpersonal relationships, social, family and professional reintegration. They are a source of difficulties (burden) for family and friends. Social cognition covers four functions: recognition of social cues; empathy; attribution of intentions to a third party, or theory of mind; and adjustment of social behaviour according to context. This study has two parts: 1/ Evaluation, using a cognitive approach, of the different components of social cognition after moderate to severe traumatic brain injury, and of its repercussions in daily life and on family and friends. 2/ Creation of a specific re-education method for the different modules of social cognition and study of its effectiveness.


Description:

First objective: to study in a systematic way in the same group of TBI patients the different domains of social cognition and the relationships between these different sub-domains in these patients, as well as the relationships between these deficits and the more global cognitive functioning (executive functions), and to evaluate their repercussions in daily life (activity limitations and participation restrictions). Second objective: to develop and evaluate the effectiveness of a specific rehabilitation protocol for social cognition, adjusted to each profile, according to the disorders of the components of social cognition found in each patient. We make the hypothesis that not all patients will present homogeneous deficits and we also wish to bring elements of knowledge on the sub-domains of social cognition that can be "mobilized" by therapeutic means based on cognitive training adapted to each patient. The methodology envisaged is based on an experimental methodology in single repeated case studies, allowing a fine analysis of the architecture of the altered cognitive processes in a given patient and to adapt the rehabilitation protocol in an individualized way.


Recruitment information / eligibility

Status Recruiting
Enrollment 80
Est. completion date December 31, 2023
Est. primary completion date September 24, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Male or female of legal age, - Having suffered a moderate to severe traumatic brain injury (Glasgow Coma Scale score of 3 to 12) at least 6 months after the trauma, - Returned home at least 3 months ago, - Having given their informed consent, - Affiliated to the social security system Exclusion Criteria: - Psychiatric history, - Persistent post-traumatic amnesia, - Instrumental disorders that interfere with taking tests (aphasia, agnosia, neurovisual disorders), - Mood disorders not stabilized under treatment, - Patient refuses to participate in the study, - Participation in another cognitive rehabiltation protocol, - Pregnant or breastfeeding woman.

Study Design


Intervention

Other:
sociale cognition
several social cognition test

Locations

Country Name City State
France SAMSAH-UEROS Arceau Anjou Angers
France Raymond Poincaré Hospital Garches
France Ueros Ugecam Garches
France FAM la vie devant soi Lomme

Sponsors (1)

Lead Sponsor Collaborator
Centre d'Investigation Clinique et Technologique 805

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary social cognition evaluation emotional and sociocognitive measurement by questionnaire 4 hours
Primary humor and global cognition attention measurement and mood evolution by questionnaire 4 hours
Primary social activity measurement activity measurement and social cognition evaluation by questionnaire 1 hour
Secondary environnemental measurement questionnaire 20 min
Secondary mood measurement questionnaire 30 min
Secondary quality of life questionnaire questionnaire 1 hour
See also
  Status Clinical Trial Phase
Completed NCT05077501 - Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Ascending Doses of ACD856 Phase 1
Not yet recruiting NCT05490628 - The Effects of Cognitive Rehabilitation on Motor Performance, Balance and Fear of Falling in Stroke Patients N/A
Active, not recruiting NCT05111275 - Cognitive Exercises in Survivors of a Prolonged ICU Stay. N/A
Recruiting NCT05201534 - Interventions in Mathematics and Cognitive Skills N/A
Recruiting NCT05464472 - Impact of Transcatheter Aortic Valve Implantation (TAVI) on Cognitive Functions
Not yet recruiting NCT06357195 - DIAMOND-Lewy Guidelines for Antipsychotic Use in Older Patients
Recruiting NCT05886114 - A Multi-domain Lifestyle Intervention Among Aged Community-residents in Zhejiang, China N/A
Withdrawn NCT04019665 - Self-screening of Cognitive Impairment in Primary Care N/A
Completed NCT00240695 - A Follow-up Study to Assess Safety and Tolerability of Galantamine Treatment in Individuals With Mild Cognitive Impairment Phase 3
Completed NCT04219774 - NeuroCognition After Carotid Recanalization Phase 2
Not yet recruiting NCT06268080 - Depth of Anesthesia on Postoperative Delirium and Cognitive After Surgery N/A
Completed NCT00695136 - The Effect of Donepezil (Aricept(Registered Trademark)) on REM Sleep in Children With Autism Phase 1/Phase 2
Recruiting NCT04911738 - VIrtual Reality Glasses Use to Improve Lateropulsion and the Post-stroke Postural Vertical N/A
Withdrawn NCT01668758 - fMRI and NIRS Imaging for Traumatic Brain Injury N/A
Completed NCT05783830 - Study Evaluating the Pharmacokinetics of a Single Microdose of ACD856 Early Phase 1
Recruiting NCT06186102 - Polyamine Treatment in Elderly Patients With Coronary Artery Disease Phase 2
Recruiting NCT05322031 - The Impact of Aripiprazole Long-acting on Myelin and Cognition in the Onset of Schizophrenia Phase 4
Completed NCT04210713 - Neuroimmune Dysfunction in Alcohol Use Disorder Phase 1
Completed NCT05077631 - Study to Evaluate the Effects of Single Ascending Oral Doses of ACD856 on Safety, Tolerability and Pharmacokinetics Phase 1
Enrolling by invitation NCT06314464 - Portable Mixed Reality-based Platform for Assessment of Progress in Multisensory Rehabilitation Strategies Post-TBI N/A